Filters
Catalog peptides
Synthesis of unnatural amino acids and other blocks

GIP (3 - 42), human

Name
GIP (3 - 42), human
Molecular structural formula
Purity
≥95%
CAS Number
1802086-25-4
Formula
C214H324N58O63S
MW
4749.38
Target
Insulin Receptor
Sequence
Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln
Sequence Shortening
EGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ
Solubility in DMSO
100 mg/mL
Solubility in water
50 mg/mL
References
[1]. V A Gault, et al. Evidence that the major degradation product of glucose-dependent insulinotropic polypeptide, GIP(3-42), is a GIP receptor antagonist in vivo. J Endocrinol. 2002 Nov;175(2):525-33.
* All products on our website are for scientific research and cannot be used in human body
Product details
Data download

GIP (3-42), human acts as a glucose-dependent insulinotropic polypeptide (GIP) receptor antagonist, moderating the insulin secreting and metabolic actions of GIP in vivo.